Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all (2017)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1016/j.jacc.2017.02.011
- Subjects: CORONARIOPATIA; DOR ABDOMINAL; TOMOGRAFIA; ISQUEMIA MIOCÁRDICA; PREVENÇÃO DE DOENÇAS; REVASCULARIZAÇÃO MIOCÁRDICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the American College of Cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 69, n. 14, p. 1771-1773, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BLANKSTEIN, Ron e BITTENCOURT, Márcio Sommer e BHATT, Deepak L. Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all. Journal of the American College of Cardiology, v. 69, n. 14, p. 1771-1773, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2017.02.011. Acesso em: 17 fev. 2026. -
APA
Blankstein, R., Bittencourt, M. S., & Bhatt, D. L. (2017). Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all. Journal of the American College of Cardiology, 69( 14), 1771-1773. doi:10.1016/j.jacc.2017.02.011 -
NLM
Blankstein R, Bittencourt MS, Bhatt DL. Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all [Internet]. Journal of the American College of Cardiology. 2017 ; 69( 14): 1771-1773.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.jacc.2017.02.011 -
Vancouver
Blankstein R, Bittencourt MS, Bhatt DL. Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all [Internet]. Journal of the American College of Cardiology. 2017 ; 69( 14): 1771-1773.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.jacc.2017.02.011 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
Informações sobre o DOI: 10.1016/j.jacc.2017.02.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
